Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.18
-0.0200-0.91%
Post-market: 2.10-0.0800-3.67%19:11 EDT
Volume:139.52K
Turnover:298.27K
Market Cap:36.80M
PE:-1.03
High:2.25
Open:2.21
Low:2.03
Close:2.20
Loading ...

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for Its International Network of Interventional Psychiatry Clinics

THOMSON REUTERS
·
02 Jan

Press Release: Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics

Dow Jones
·
02 Jan

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
31 Dec 2024

Best Momentum Stocks to Buy for December 30th

Zacks
·
30 Dec 2024

NRx Pharmaceuticals announces first section of NDA for NRX-100

TIPRANKS
·
30 Dec 2024

BRIEF-NRX Pharma Files Initial Section Of U.S. New Drug Application To The FDA For NRX-100

Reuters
·
30 Dec 2024

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (Iv Ketamine) for the Treatment of Suicidal Depression

THOMSON REUTERS
·
30 Dec 2024

NRX Pharmaceuticals Inc - Completion of Nda Filing Expected in Q1 2025

THOMSON REUTERS
·
30 Dec 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression

PR Newswire
·
30 Dec 2024

New Strong Buy Stocks for December 30th

Zacks
·
30 Dec 2024

New Strong Buy Stocks for December 26th

Zacks
·
26 Dec 2024

New Strong Buy Stocks for December 24th

Zacks
·
24 Dec 2024

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024

PR Newswire
·
26 Nov 2024

NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Nov 2024

BRIEF-NRx Pharmaceuticals Announces Publication Of Paper Entitled "Quality Assurance Of Depression Ratings In Psychiatric Clinical Trials"

Reuters
·
25 Nov 2024

NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

THOMSON REUTERS
·
25 Nov 2024